Biogen Inc. (LON:0R1B)
London flag London · Delayed Price · Currency is GBP · Price in USD
133.27
-1.28 (-0.95%)
At close: Jul 11, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Multiple Sclerosis
4.35B
Log In
Log In
Log In
Log In
Upgrade
Multiple Sclerosis Growth
-8.36%
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
7.73%
Log In
Log In
Log In
Log In
Upgrade
Rare Disease
1.99B
Log In
Log In
Log In
Log In
Upgrade
Rare Disease Growth
19.28%
Log In
Log In
Log In
Log In
Upgrade
Biosimilars
793.10M
Log In
Log In
Log In
Log In
Upgrade
Biosimilars Growth
0.32%
Log In
Log In
Log In
Log In
Upgrade
Alzheimer's Disease
-
Log In
Log In
Log In
Log In
Upgrade
Other Product
82.50M
Log In
Log In
Log In
Log In
Upgrade
Other Product Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
7.73%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
4.88%
Log In
Log In
Log In
Log In
Upgrade
United States
3.24B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
1.85%
Log In
Log In
Log In
Log In
Upgrade
International
3.98B
Log In
Log In
Log In
Log In
Upgrade
International Growth
-0.65%
Log In
Log In
Log In
Log In
Upgrade
Other
2.46B
Log In
Log In
Log In
Log In
Upgrade
Other Growth
4.88%
Log In
Log In
Log In
Log In
Upgrade